Ocean Biomedical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	10.93	7.71	28.41
Research & Development	0.89	8.41	33.93
Operating Expenses	11.81	16.12	62.35
Operating Income	-11.81	-16.12	-62.35
Interest Expense / Income	1.26	0	0
Other Expense / Income	85.52	1.24	-0
Pretax Income	-98.59	-17.36	-62.34
Net Income	-98.59	-17.36	-62.34
Shares Outstanding (Basic)	27	17	17
Shares Outstanding (Diluted)	27	17	17
Shares Change	13.91%	0.05%	-
EPS (Basic)	-3.91	-0.99	-3.57
EPS (Diluted)	-3.91	-0.99	-3.57
Free Cash Flow	-8.6	-0.99	-1.05
Free Cash Flow Per Share	-0.32	-0.06	-0.06
EBITDA	-97.33	-17.36	-62.34
EBIT	-97.33	-17.36	-62.34

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).